Could Usana Health Sciences Inc (NYSE:USNA) See a Reversal After Less Sellers Came In?

March 14, 2018 - By Adrian Erickson

 Could Usana Health Sciences Inc (NYSE:USNA) See a Reversal After Less Sellers Came In?

Investors sentiment decreased to 1.25 in 2017 Q3. Its down 0.22, from 1.47 in 2017Q2. It worsened, as 22 investors sold USANA Health Sciences, Inc. shares while 37 reduced holdings. 30 funds opened positions while 44 raised stakes. 10.23 million shares or 3.93% less from 10.64 million shares in 2017Q2 were reported.
Matarin Capital Mngmt Limited holds 166,414 shares or 0.82% of its portfolio. Citadel Advsr Ltd Llc accumulated 13,278 shares. Bancorp Of New York Mellon has invested 0% in USANA Health Sciences, Inc. (NYSE:USNA). Qs Investors Ltd Liability Com accumulated 0% or 14 shares. Bessemer has invested 0% in USANA Health Sciences, Inc. (NYSE:USNA). 700 were reported by Quantbot Technologies Lp. Pacad Ltd stated it has 3,000 shares or 0.04% of all its holdings. Guggenheim Ltd Co accumulated 35,035 shares. Moreover, American International Gru has 0% invested in USANA Health Sciences, Inc. (NYSE:USNA) for 7,778 shares. Ameriprise invested in 45,928 shares. California State Teachers Retirement System holds 18,551 shares. Great West Life Assurance Communication Can reported 1,054 shares stake. Hbk Invests Lp holds 0% of its portfolio in USANA Health Sciences, Inc. (NYSE:USNA) for 5,100 shares. Public Employees Retirement System Of Ohio holds 0% or 13,103 shares in its portfolio. Victory Capital Mngmt has 0% invested in USANA Health Sciences, Inc. (NYSE:USNA) for 2,662 shares.

Since September 15, 2017, it had 0 insider buys, and 18 insider sales for $79.48 million activity. 38,223 shares valued at $2.73M were sold by Gull Global Ltd on Friday, February 2. FULLER GILBERT A sold $114,590 worth of stock. IIEKKING G DOUG sold $196,389 worth of USANA Health Sciences, Inc. (NYSE:USNA) on Wednesday, March 7. Jones Paul A. sold 10,696 shares worth $866,376. On Thursday, February 15 the insider Noot Walter sold $236,775.

The stock of Usana Health Sciences Inc (NYSE:USNA) registered a decrease of 0.48% in short interest. USNA’s total short interest was 787,200 shares in March as published by FINRA. Its down 0.48% from 791,000 shares, reported previously. With 82,700 shares average volume, it will take short sellers 10 days to cover their USNA’s short positions. The short interest to Usana Health Sciences Inc’s float is 7.93%.

The stock increased 1.80% or $1.45 during the last trading session, reaching $81.9. About 106,791 shares traded or 10.51% up from the average. USANA Health Sciences, Inc. (NYSE:USNA) has risen 6.87% since March 14, 2017 and is uptrending. It has underperformed by 9.83% the S&P500.

USANA Health Sciences, Inc. develops, makes, and sells science nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company has market cap of $1.97 billion. The firm offers USANA Nutritionals Essentials product line, which includes vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It has a 32.37 P/E ratio. It also provides Sensé—beautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; and other products for prenatal, infant, and young child age groups.

USANA Health Sciences, Inc. (NYSE:USNA) Ratings Coverage

Among 3 analysts covering USANA Health Science (NYSE:USNA), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. USANA Health Science had 10 analyst reports since August 6, 2015 according to SRatingsIntel. Pivotal Research upgraded the stock to “Hold” rating in Wednesday, August 5 report. DA Davidson upgraded the shares of USNA in report on Wednesday, September 16 to “Buy” rating. The stock has “Buy” rating by Pivotal Research on Wednesday, February 8. The firm has “Buy” rating by Sidoti given on Friday, October 16. As per Thursday, August 6, the company rating was downgraded by DA Davidson. Pivotal Research maintained the shares of USNA in report on Wednesday, October 25 with “Buy” rating. The company was downgraded on Wednesday, January 24 by Sidoti. The firm has “Hold” rating by Pivotal Research given on Monday, May 1.

More important recent USANA Health Sciences, Inc. (NYSE:USNA) news were published by: which released: “USANA Health Sciences’ (USNA) Q4 2017 Results – Earnings Call Transcript” on February 07, 2018, also published article titled: “USANA Health Sciences Reports Third Quarter Financial Results”, published: “USANA Health Sciences Provides Estimated Impact of US Tax Reform” on January 08, 2018. More interesting news about USANA Health Sciences, Inc. (NYSE:USNA) was released by: and their article: “Steady Growth With USANA Health Sciences” with publication date: October 26, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: